Nucleolar Disruption Ensures Nuclear Accumulation of p21 upon DNA Damage

Traffic

Volumn 11, Issue 6, 2010, Pages 743-755

  Abella, Neus ^a   Brun, Sonia ^a   Calvo, Maria ^a   Tapia, Olga ^b   Weber, Jason D ^c   Berciano, Maria T ^b   Lafarga, Miguel ^b   Bachs, Oriol ^a   Agell, Neus ^a  

^a UNIVERSITY OF BARCELONA   (Spain)

^b INSTITUTO DE INVESTIGACIONES BIOMÉDICAS ALBERTO SOLS   (Spain)

^c WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

DNA damage; NPM B23; Nuclear export; Nucleolus; P21

Indexed keywords

ATM PROTEIN; NUCLEOPHOSMIN; NUCLEOPLASMIN; PROTEIN; PROTEIN P21; PROTEIN P53; CDKN1A PROTEIN, HUMAN; CYCLIN DEPENDENT KINASE INHIBITOR 1A; NUCLEAR PROTEIN;

ARTICLE; ATAXIA TELANGIECTASIA; CELL DISRUPTION; CELL STRUCTURE; CYTOPLASM; DNA DAMAGE; HUMAN; HUMAN CELL; MOLECULAR DYNAMICS; NUCLEOLUS; PRIORITY JOURNAL; STEADY STATE; BLEACHING; CELL CYCLE; CELL FRACTIONATION; CELL NUCLEUS; CHEMISTRY; DOMINANT GENE; FLUORESCENCE MICROSCOPY; IMMUNOHISTOCHEMISTRY; METABOLISM; METHODOLOGY; MUTATION; PLASMID; TUMOR CELL LINE;

CELL CYCLE; CELL LINE, TUMOR; CELL NUCLEOLUS; CELL NUCLEUS; CYCLIN-DEPENDENT KINASE INHIBITOR P21; DNA DAMAGE; GENES, DOMINANT; HUMANS; IMMUNOHISTOCHEMISTRY; MICROSCOPY, FLUORESCENCE; MUTATION; NUCLEAR PROTEINS; PHOTOBLEACHING; PLASMIDS; SUBCELLULAR FRACTIONS;

EID: 77953410517     PISSN: 13989219     EISSN: 16000854     Source Type: Journal    
DOI: 10.1111/j.1600-0854.2010.01063.x     Document Type: Article

References (46)

1. El-Deiry WS, Tokino T, Velculescu VE, Levy DB, Parsons R, Trent JM, Lin D, Mercer WE, Kinzler KW, Vogelstein B. WAF1, a potential mediator of p53 tumor suppression. Cell 1993, 75:817-825.
2. Noda A, Ning Y, Venable SF, Pereira-Smith OM, Smith JR. Cloning of senescent cell-derived inhibitors of DNA synthesis using an expression screen. Exp Cell Res 1994, 211:90-98.
3. Sherr CJ, Roberts JM. CDK inhibitors: positive and negative regulators of G1-phase progression. Genes Dev 1999, 13:1501-1512.
4. Gartel AL, Tyner AL. The role of the cyclin-dependent kinase inhibitor p21 in apoptosis. Mol Cancer Ther 2002, 1:639-649.
5. Abbas T, Dutta A. p21 in cancer: intricate networks and multiple activities. Nat Rev Cancer 2009, 9:400-414.
6. Dotto GP. p21(WAF1/Cip1): more than a break to the cell cycle? Biochim Biophys Acta 2000, 1471:M43-M56.
7. Carrascal M, Carujo S, Bachs O, Abian J. Identification of p21(Cip1) binding proteins by gel electrophoresis and capillary liquid chromatography microelectrospray tandem mass spectrometry. Proteomics 2002, 2:455-468.
8. Rodriguez-Vilarrupla A, Diaz C, Canela N, Rahn HP, Bachs O, Agell N. Identification of the nuclear localization signal of p21(cip1) and consequences of its mutation on cell proliferation. FEBS Lett 2002, 531:319-323.
9. Blagosklonny MV. Are p27 and p21 cytoplasmic oncoproteins? Cell Cycle 2002, 1:391-393.
10. Coqueret O. New roles for p21 and p27 cell-cycle inhibitors: a function for each cell compartment? Trends Cell Biol 2003, 13:65-70.
11. Zhou BP, Liao Y, Xia W, Spohn B, Lee MH, Hung MC. Cytoplasmic localization of p21Cip1/WAF1 by Akt-induced phosphorylation in HER-2/neu-overexpressing cells. Nature Cell Biol 2001, 3:245-252.
12. Mercer SE, Ewton DZ, Deng X, Lim S, Mazur TR, Friedman E. Mirk/dyrk1B mediates survival during the differentiation of C2C12 myoblasts. J Biol Chem 2005, 280:25788-25801.
13. Rodriguez-Vilarrupla A, Jaumot M, Abella N, Canela N, Brun S, Diaz C, Estanyol JM, Bachs O, Agell N. Binding of calmodulin to the carboxy-terminal region of p21 induces nuclear accumulation via inhibition of protein kinase C-mediated phosphorylation of Ser153. Mol Cell Biol 2005, 25:7364-7374.
14. Agell N, Jaumot M, Rodriguez-Vilarrupla A, Brun S, Abella N, Canela N, Estanyol JM. The diverging roles of calmodulin and PKC in the regulation of p21 intracellular localization. Cell Cycle 2006, 5:3-6.
15. Shiloh Y. The ATM-mediated DNA-damage response: taking shape. Trends Biochem Sci 2006, 31:402-410.
16. Levine AJ. P53, the cellular gatekeeper for growth and division. Cell 1997, 88:323-331.
17. Harris SL, Levine AJ. The p53 pathway: positive and negative feedback loops. Oncogene 2005, 24:2899-2908.
18. Janicke RU, Sohn D, Essmann F, Schulze-Osthoff K. The multiple battles fought by anti-apoptotic p21. Cell Cycle 2007, 6:407-413.
19. Zatsepina OV, Voronkova LN, Sakharov VN, Chentsov YS. Ultrastructural changes in nucleoli and fibrillar centers under the effect of local ultraviolet microbeam irradiation of interphase culture cells. Exp Cell Res 1989, 181:94-104.
20. Tembe V, Henderson BR. Protein trafficking in response to DNA damage. Cell Signal 2007, 19:1113-1120.
21. Boisvert FM, van Koningsbruggen S, Navascues J, Lamond AI. The multifunctional nucleolus. Nat Rev Mol Cell Biol 2007, 8:574-585.
22. Rubbi CP, Milner J. Disruption of the nucleolus mediates stabilization of p53 in response to DNA damage and other stresses. EMBO J 2003, 22:6068-6077.
23. Kurki S, Peltonen K, Latonen L, Kiviharju TM, Ojala PM, Meek D, Laiho M. Nucleolar protein NPM interacts with HDM2 and protects tumor suppressor protein p53 from HDM2-mediated degradation. Cancer Cell 2004, 5:465-475.
24. Colombo E, Marine JC, Danovi D, Falini B, Pelicci PG. Nucleophosmin regulates the stability and transcriptional activity of p53. Nat Cell Biol 2002, 4:529-533.
25. Lee C, Smith BA, Bandyopadhyay K, Gjerset RA. DNA damage disrupts the p14ARF-B23(nucleophosmin) interaction and triggers a transient subnuclear redistribution of p14ARF. Cancer Res 2005, 65:9834-9842.
26. Gjerset RA, Bandyopadhyay K. Regulation of p14ARF through subnuclear compartmentalization. Cell Cycle 2006, 5:686-690.
27. Sherr CJ, Weber JD. The ARF/p53 pathway. Curr Opin Genet Dev 2000, 10:94-99.
28. Burden DA, Osheroff N. Mechanism of action of eukaryotic topoisomerase II and drugs targeted to the enzyme. Biochim Biophys Acta 1998, 1400:139-154.
29. Pena E, Berciano MT, Fernandez R, Crespo P, Lafarga M. Stress-induced activation of c-Jun N-terminal kinase in sensory ganglion neurons: accumulation in nuclear domains enriched in splicing factors and distribution in perichromatin fibrils. Exp Cell Res 2000, 256:179-191.
30. Chusainow J, Ajuh PM, Trinkle-Mulcahy L, Sleeman JE, Ellenberg J, Lamond AI. FRET analyses of the U2AF complex localize the U2AF35/U2AF65 interaction in vivo and reveal a novel self-interaction of U2AF35. RNA 2005, 11:1201-1214.
31. Pinol-Roma S, Dreyfuss G. Transcription-dependent and transcription-independent nuclear transport of hnRNP proteins. Science 1991, 253:312-314.
32. Maggi LB, Kuchenruether M, Dadey DY, Schwope RM, Grisendi S, Townsend RR, Pandolfi Weber JD. Nucleophosmin serves as a rate-limiting nuclear export chaperone for the mammalian ribosome. Mol Cell Biol 2008, 28:7050-7065.
33. Cazzalini O, Perucca P, Valsecchi F, Stivala LA, Bianchi L, Vannini V, Prosperi E. Intracellular localization of the cyclin-dependent kinase inhibitor p21CDKN1A-GFP fusion protein during cell cycle arrest. Histochem Cell Biol 2004, 121:377-381.
34. Hu J, Cai XF, Yan G. Alphavirus M1 induces apoptosis of malignant glioma cells via downregulation and nucleolar translocation of p21WAF1/CIP1 protein. Cell Cycle 2009, 8:3328-3339.
35. Bonetti P, Davoli T, Sironi C, Amati B, Pelicci PG, Colombo E. Nucleophosmin and its AML-associated mutant regulate c-Myc turnover through Fbw7 gamma. J Cell Biol 2008, 182:19-26.
36. Pestov DG, Strezoska Z, Lau LF. Evidence of p53-dependent cross-talk between ribosome biogenesis and the cell cycle: effects of nucleolar protein Bop1 on G(1)/S transition. Mol Cell Biol 2001, 21:4246-4255.
37. Xiao J, Zhang Z, Chen GG, Zhang M, Ding Y, Fu J, Li M, Yun JP. Nucleophosmin/B23 interacts with p21WAF1/CIP1 and contributes to its stability. Cell Cycle 2009, 8:889-895.
38. Falini B, Nicoletti I, Martelli MF, Mecucci C. Acute myeloid leukemia carrying cytoplasmic/mutated nucleophosmin (NPMc+ AML): biologic and clinical features. Blood 2007, 109:874-885.
39. Arabi A, Wu S, Ridderstrale K, Bierhoff H, Shiue C, Fatyol K, Fahlen S, Hydbring P, Soderberg O, Grummt I, Larsson LG, Wright AP. c-Myc associates with ribosomal DNA and activates RNA polymerase I transcription. Nat Cell Biol 2005, 7:303-310.
40. Yu Y, Maggi LB, Brady SN, Apicelli AJ, Dai MS, Lu H, Weber JD. Nucleophosmin is essential for ribosomal protein L5 nuclear export. Mol Cell Biol 2006, 26:3798-3809.
41. Torrano V, Navascues J, Docquier F, Zhang R, Burke LJ, Chernukhin I, Farrar D, Leon J, Berciano MT, Renkawitz R, Klenova E, Lafarga M, Delgado MD. Targeting of CTCF to the nucleolus inhibits nucleolar transcription through a poly(ADP-ribosyl)ation-dependent mechanism. J Cell Sci 2006, 119:1746-1759.
42. Andersen JS, Lyon CE, Fox AH, Leung AK, Lam YW, Steen H, Mann M, Lamond AI. Directed proteomic analysis of the human nucleolus. Curr Biol 2002, 12:1-11.
43. Boisvert FM, Hendzel MJ, Bazett-Jones DP. Promyelocytic leukemia (PML) nuclear bodies are protein structures that do not accumulate RNA. J Cell Biol 2000, 148:283-292.
44. Bosser R, Faura M, Serratosa J, Renau-Piqueras J, Pruschy M, Bachs O. Phosphorylation of rat liver heterogeneous nuclear ribonucleoproteins A2 and C can be modulated by calmodulin. Mol Cell Biol 1995, 15:661-670.
45. Arabi A, Rustum C, Hallberg E, Wright AP. Accumulation of c-Myc and proteasomes at the nucleoli of cells containing elevated c-Myc protein levels. J Cell Sci 2003, 116:1707-1717.
46. Rabut G, Ellenberg J. Photobleaching techniques to study mobility and molecular dynamics of proteins in live cells: FRAP, iFRAP and FLIP. Live Imaging: A Laboratory Manual 2005, Goldman RD, Spector DL. In:, editors., Cold Spring Harbor, New York, Cold Spring Harbor Press